Skip to main navigation

The link is opening in a new window or tab that may or may not accessible Opens an external site Opens an external site in a new window

Pre-Header Contact

800-449-3353 | custserv@rockwellmed.com |

Footer Socials

Pre-Header Menu

Careers | Contact Us

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors

Investor Relations

Press Releases

Main navigation

Investor Home
Press Releases
Events & Presentations
Corporate Governance
Management
Annual Meeting
Financial Information
Stock Information
Investor FAQs
Contact Us
Shareholder Tools

Press Releases

Year

Jun 11, 2021

Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates

PDF Version

Jun 08, 2021

Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic® in Turkey

PDF Version

Jun 03, 2021

Rockwell Medical, Inc. to Present at the 2021 LD Micro Invitational XI

PDF Version

May 17, 2021

Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational Update

PDF Version

May 03, 2021

Rockwell Medical, Inc. to Report First Quarter 2021 Financial and Operating Results on May 17, 2021

PDF Version

Apr 27, 2021

Rockwell Medical Announces Marketing Approval of Triferic® AVNU™ in Canada

PDF Version

Apr 22, 2021

Rockwell Medical Presents Data on Diagnosis and Management of Iron Deficiency Anemia in Home Parenteral Nutrition Patients at the NHIA 2021 Annual Conference

PDF Version

Mar 31, 2021

Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update

PDF Version

Mar 18, 2021

Rockwell Medical, Inc. to Report Fourth Quarter and Full Year 2020 Financial and Operating Results on March 31, 2021

PDF Version

Mar 04, 2021

Rockwell Medical, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

PDF Version

Pagination

Current page 1
Page 2
Next page
Last page

Shareholder Tools

Snapshot

Email Alerts

RSS News Feeds

Have any questions?

Phone 248 432-1997

invest@rockwellmed.com

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors
Contact

Footer Socials